Indeed, high levels of circulating IGF-1, IGF-binding protein-1, and soluble IL-6 receptor, as well as low adiponectin levels have been consistently associated with MM risk [55–58] and progression [58]. Here, IGF1 is linked to Miyoshi myopathy.